Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Deep Learning-Based Techniques in Glioma Brain Tumor Segmentation Using Multi-Parametric Mri: A Review on Clinical Applications and Future Outlooks Publisher Pubmed



Ghadimi DJ1 ; Vahdani AM2 ; Karimi H3 ; Ebrahimi P4 ; Fathi M1 ; Moodi F5, 6 ; Habibzadeh A7 ; Khodadadi Shoushtari F6 ; Valizadeh G6 ; Mobarak Salari H6 ; Saligheh Rad H6, 8
Authors
Show Affiliations
Authors Affiliations
  1. 1. School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. Image Guided Surgery Lab, Research Center for Biomedical Technologies and Robotics, Advanced Medical Technologies and Equipment Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. School of Medicine, Iran University of Medical Sciences, Tehran, Iran
  6. 6. Quantitative MR Imaging and Spectroscopy Group (QMISG), Tehran University of Medical Sciences, Tehran, Iran
  7. 7. Student Research Committee, Fasa University of Medical Sciences, Fasa, Iran
  8. 8. Department of Medical Physics and Biomedical Engineering, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of Magnetic Resonance Imaging Published:2025


Abstract

This comprehensive review explores the role of deep learning (DL) in glioma segmentation using multiparametric magnetic resonance imaging (MRI) data. The study surveys advanced techniques such as multiparametric MRI for capturing the complex nature of gliomas. It delves into the integration of DL with MRI, focusing on convolutional neural networks (CNNs) and their remarkable capabilities in tumor segmentation. Clinical applications of DL-based segmentation are highlighted, including treatment planning, monitoring treatment response, and distinguishing between tumor progression and pseudo-progression. Furthermore, the review examines the evolution of DL-based segmentation studies, from early CNN models to recent advancements such as attention mechanisms and transformer models. Challenges in data quality, gradient vanishing, and model interpretability are discussed. The review concludes with insights into future research directions, emphasizing the importance of addressing tumor heterogeneity, integrating genomic data, and ensuring responsible deployment of DL-driven healthcare technologies. Evidence Level: N/A. Technical Efficacy: Stage 2. © 2024 International Society for Magnetic Resonance in Medicine.
Experts (# of related papers)